Loading page…

Sunil Healthcare Ltd (SUNLOC) · mywealthgrid

About

Sunil Healthcare Ltd operates in Pharmaceuticals within the Healthcare sector.

Face value: ₹10

Market cap

₹72 Cr

P/E

11.6×

P/B

1.4×

Dividend yield

ROE

13.3%

ROCE

18.6%

Debt / equity

0.69

OPM

14.6%

EPS (TTM)

₹6.1

Book value

₹48.7

52-week high

₹83.0

52-week low

₹59.9

₹70.1-12.5%1Y

Beta

1.07

Moves with the index

Volatility (1y)

50.9%

Annualised, daily returns

RSI (14)

29.9

Oversold territory

Rel. strength (1y)

-21.1%

Behind the market

Beta is measured against NIFTY 50 over three years of weekly returns — 1 moves with the index, above 1 amplifies it, below 1 damps it.

Quick read

rule-based

Pros

+High promoter holding of 73.5% with no pledge

Cons

−Low return on equity of 5.9% (3-yr avg)

Research score

Structured signal from quality, growth, valuation and momentum.

53/100

Business quality: 39
Valuation: 93
Momentum: 27

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Torrent Pharmaceuticals LimitedTORNTPHARMTORNTPHARM	₹1,61,325 Cr	₹1,76,123 Cr	₹15,723 Cr	₹5,191 Cr	32.6%	₹2,181 Cr	15.3%	14.5%	27.1%	163
Zydus Lifesciences LimitedZYDUSLIFEZYDUSLIFE	₹1,14,284 Cr	₹1,26,053 Cr	₹28,592 Cr	₹8,316 Cr	31.2%	₹4,513 Cr	18.9%	23.4%	19.7%	212
Laurus Labs LimitedLAURUSLABSLAURUSLABS	₹1,07,176 Cr	₹1,09,573 Cr	₹7,270 Cr	₹2,034 Cr	26.1%	₹1,093 Cr	13.1%	21.3%	18.2%	263
Mankind Pharma LimitedMANKINDMANKIND	₹1,04,696 Cr	₹1,11,007 Cr	₹14,738 Cr	₹3,827 Cr	25.3%	₹2,068 Cr	13.6%	14.2%	12.5%	117
Aurobindo Pharma LimitedAUROPHARMAAUROPHARMA	₹97,389 Cr	₹1,05,065 Cr	₹34,935 Cr	₹7,085 Cr	20.3%	₹3,713 Cr	10.4%	14.7%	9.9%	252
Lupin LimitedLUPINLUPIN	₹92,866 Cr	₹98,777 Cr	₹29,967 Cr	₹9,538 Cr	31.5%	₹5,529 Cr	19.2%	34.2%	26.9%	181
Glenmark Pharmaceuticals LimitedGLENMARKGLENMARK	₹65,781 Cr	₹65,781 Cr	₹17,737 Cr	₹4,797 Cr	26.9%	₹1,496 Cr	8%	37.8%	0%	83
Alkem Laboratories LimitedALKEMALKEM	₹62,431 Cr	₹64,055 Cr	₹15,081 Cr	₹3,032 Cr	20.4%	₹2,158 Cr	16%	21.5%	17.8%	152
Biocon LimitedBIOCONBIOCON	₹60,413 Cr	₹75,238 Cr	₹17,321 Cr	₹3,536 Cr	20.4%	₹495 Cr	2.2%	3.9%	1.4%	85
Abbott India LimitedABBOTINDIAABBOTINDIA	₹56,901 Cr	—	₹4,310 Cr	₹921 Cr	27.3%	₹691 Cr	22.4%	44.1%	34.5%	110
Ipca Laboratories LimitedIPCALABIPCALAB	₹49,299 Cr	₹50,003 Cr	₹10,126 Cr	₹2,232 Cr	20.5%	₹1,310 Cr	12.3%	17.8%	15.2%	308
Gland Pharma LimitedGLANDGLAND	₹47,428 Cr	₹47,671 Cr	₹6,725 Cr	₹1,751 Cr	25.3%	₹1,129 Cr	16%	14.8%	10.5%	255

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2021	Mar 2022
	91	119
COGS	43	48
Gross profit	48	71
	43	53
Operating profit (EBITDA)	5	17
OPM %	5.8%	14.6%
Depreciation	6	6
Interest	5	3
	6	2
Profit before tax	-1	9
Tax	0	3
Tax %	14.6%	30.7%
PAT	-1	6
PAT margin %	-0.7%	5.4%
EPS (₹)	-63.8	623.8
EPS adjusted (₹)	-0.6	6.1
Annual report	Annual report for Mar 2021	Annual report for Mar 2022

₹ Cr	Mar 2020	Mar 2021	Mar 2022
Equity capital	10	10	10
Reserves	—	33	40
Minority interest	—	0	—
	—	49	34
	—	28	26
Total equity & liabilities	—	121	110
	70	70	70
CWIP	—	0	2
Investments	—	1	1
	—	50	37
Total assets	—	121	110

₹ Cr	Mar 2021	Mar 2022
	17	23
	-11	-4
	-6	-19
Net cash flow	-1	-0
Free cash flow	17	22
CFO / Operating profit %	321.2%	129.4%

Compounded sales growth

7 years: —
5 years: —
3 years: —
1 year: 32%

Stock price CAGR

10 years: —
5 years: 18%
3 years: 10%
1 year: -12%

Return on equity

7 years: —
5 years: —
3 years: —
Last year: 13%

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2021	Mar 2022
Margins
Gross margin %	52.9%	59.3%
EBITDA margin %	5.8%	14.6%
EBIT margin %	-0.9%	9.3%
PAT margin %	-0.7%	5.4%
Working capital
Receivable days	94	58
Inventory days	117	83
Payable days	109	65
NWC days	102	76
Leverage
Current ratio	0.91	0.87
Debt to EBITDA	9.29	1.97
Debt to equity	1.12	0.69
Interest coverage	0.9	3.7
Asset turnover	0.75	1.09
Return ratios
Return on assets %	-0.5%	5.9%
Return on capital employed %	7.1%	18.6%
Return on equity %	-1.5%	12.9%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%
FII	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	26.37%	26.37%	26.37%	26.37%	26.37%	26.37%	26.37%	26.37%	26.37%	26.37%	26.37%	26.37%
No. of shareholders	—	—	—	—	—	—	—	—	6,430	6,399	6,364	6,310

Promoter holding up 0 percentage points since Sep 2023.

1 deal · 2 May 2024 – 2 May 2024

Date	Client	Type	Venue	Side	Quantity	Price	Value
2 May 2024	SHAILESH KUMAR	Bulk	BSE	Buy	64,000	₹97.33	₹0.62 Cr

1–1 of 1

1 / 1

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.

Mr. ANIL KUMAR KHAITANExecutive Director-Chairperson related to Promoter-CEO-MD
Mr. Pawan RathiChief Financial Officer
Mr. SANJAY KUMAR KAUSHIKNon-Executive - Non Independent Director
Mr. RAKESH MOHANNon-Executive - Independent Director
Mr. HARISH PAL KUMARNon-Executive - Independent Director
Mr. KRISHNA VENKATCHALAM RAJANNon-Executive - Non Independent Director
Mr. BEJON KUMAR MISRANon-Executive - Independent Director
Mrs. MUDITA CHATURVEDINon-Executive - Independent Director
Mr. JAI PRAKASH SINGHNon-Executive - Independent Director
Mr. Satyendu PattnaikCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Sunil Healthcare Ltd. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Annual reports

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

1

Board meeting to consider results13 Aug 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

12 announcementsExport CSV

29 Sept 2026, 4:48 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

AGM PDF

Loading announcements…

Date	Category	Subject	Filing
29 Sept 2026, 4:48 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Scrutinizer''s Report	PDF
28 Sept 2026, 2:53 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Outcome of AGM	PDF
14 Sept 2026, 5:48 pm	Corp. Action Book Closure	Intimation Of Book Closure For The Purpose Of 52Nd AGM And Cut Off Date For Remote-Evoting/E-Voting	PDF
3 Sept 2026, 12:34 pm	Company Update Newspaper Publication	Announcement under Regulation 30 (LODR)-Newspaper Publication	PDF
2 Sept 2026, 4:16 pm	Others Reg. 34 (1) Annual Report	Reg. 34 (1) Annual Report.	PDF
2 Sept 2026, 4:03 pm	AGM/EGM AGM	Notice Of 52Nd Annual General Meeting Of The Company/Remote E-Voting Facility/E-Voting Facility And Other Information	PDF
21 Aug 2026, 1:11 pm	Company Update Newspaper Publication	Announcement under Regulation 30 (LODR)-Newspaper Publication	PDF
15 Aug 2026, 2:39 pm	Company Update Newspaper Publication	Announcement under Regulation 30 (LODR)-Newspaper Publication	PDF

Sunil Healthcare Ltd

Sunil Healthcare Ltd

About

Risk & technicals

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Stock price CAGR

Return on equity

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Events

Board meetings1

Announcements

Board meetings1

Ratio timeline

Quarterly record

Bulk & block deals

Board and management

Not in the F&O segment

No fund holdings on record

Announcements

Annual reports

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Stock price CAGR

Return on equity

1

1